logo
Product categories

EbookNice.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link.  https://ebooknice.com/page/post?id=faq


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookNice Team

Prademagene zamikeracel for recessive dystrophic epidermolysis bullosa wounds (VIITAL): a two-centre, randomised, open-label, intrapatient-controlled phase 3 trial by Prof Jean Y Tang MD & M Peter Marinkovich MD & Prof Karen Wiss MD & Daniel McCarthy BS & Amanda Truesdale MA & Albert S Chiou MD & Edward Eid MD & Joyce K McIntyre MD & Irene Bailey AIMBS & Louise K Furukawa MD & Emily S Gorell DO & Nicki Harris BA &... instant download

  • SKU: EBN-239573132
Zoomable Image
$ 32 $ 40 (-20%)

Status:

Available

4.4

6 reviews
Instant download (eBook) Prademagene zamikeracel for recessive dystrophic epidermolysis bullosa wounds (VIITAL): a two-centre, randomised, open-label, intrapatient-controlled phase 3 trial after payment.
Authors:Prof Jean Y Tang MD & M Peter Marinkovich MD & Prof Karen Wiss MD & Daniel McCarthy BS & Amanda Truesdale MA & Albert S Chiou MD & Edward Eid MD & Joyce K McIntyre MD & Irene Bailey AIMBS & Louise K Furukawa MD & Emily S Gorell DO & Nicki Harris BA &...
Pages:updating ...
Year:2025
Publisher:x
Language:english
File Size:1.69 MB
Format:pdf
Categories: Ebooks

Product desciption

Prademagene zamikeracel for recessive dystrophic epidermolysis bullosa wounds (VIITAL): a two-centre, randomised, open-label, intrapatient-controlled phase 3 trial by Prof Jean Y Tang MD & M Peter Marinkovich MD & Prof Karen Wiss MD & Daniel McCarthy BS & Amanda Truesdale MA & Albert S Chiou MD & Edward Eid MD & Joyce K McIntyre MD & Irene Bailey AIMBS & Louise K Furukawa MD & Emily S Gorell DO & Nicki Harris BA &... instant download

The Lancet, 406 (2025) 163-173. doi:10.1016/S0140-6736(25)00778-0
*Free conversion of into popular formats such as PDF, DOCX, DOC, AZW, EPUB, and MOBI after payment.

Related Products